Validation of a Swedish Version of the Cancer Dyspnea Scale

Henoch, Ingela; Bergman, Bengt; Gaston‐Johansson, Fannie

doi:10.1016/j.jpainsymman.2006.02.002

Cited by 19 publications

(19 citation statements)

References 132 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To better reflect the patient's experience rather than focusing on physiologic parameters, Tanaka et al 41 developed the Cancer Dyspnea Scale, a 12-item multidimensional dyspnea scale for patients with cancer to assess effort, anxiety, and discomfort. Originally validated in a Japanese population, it has subsequently been validated in Swedish-speaking 42 and English-speaking 43 cohorts. This effort represents a step forward in incorporating the patient's symptom experience into dyspnea assessment, but falls short of assessing the full impact of dyspnea.…”

Section: Measurement Of Dyspneamentioning

confidence: 99%

Dyspnea Review for the Palliative Care Professional: Assessment, Burdens, and Etiologies

Kamal

Maguire

Wheeler

et al. 2011

Journal of Palliative Medicine

View full text Add to dashboard Cite

show abstract

Section: Measurement Of Dyspneamentioning

confidence: 99%

Dyspnea Review for the Palliative Care Professional: Assessment, Burdens, and Etiologies

Kamal

Maguire

Wheeler

et al. 2011

Journal of Palliative Medicine

View full text Add to dashboard Cite

show abstract

“…Three studies (15,17,18) confirm that CDS has a three-factor structure (table 3), but we do not have sufficient data to assess the instruments' structural validity (table 5).…”

Section: Cancer Dyspnea Scale (Cds)mentioning

confidence: 92%

“…The result for hypotheses testing was negative in two studies (16,18) and positive in two studies (15,17) (table 4). As such the results are contradictory, which makes it difficult to conclude univocally ( …”

Section: Cancer Dyspnea Scale (Cds)mentioning

confidence: 99%

Kartleggingsverktøy for pustebesvær hos palliative pasienter

Solvåg¹,

Titlestad²,

Brurberg³

2016

Sykepleien

View full text Add to dashboard Cite

for relevance and quality assured these by means of the COSMIN-checklist. We performed a best evidence synthesis to summarise the measurement properties of each included PROM.Results: We screened 1948 references for relevance, and included 15 studies evaluating the measurement properties of four different PROMs: CDS, DMQ, SRI and a respiratory symptom checklist. None of the included instruments were validated directly for use in a palliative setting, but they generally showed promising measurement properties in other relevant settings. We still lack data on important measurement properties for all the available instruments, and currently, only SRI seems to be available in a Norwegian validated version. Further research is therefore needed to translate and validate the PROMs for use in palliative care in Norway.

show abstract

“…Multidimensional instruments for breathlessness assessment have also been introduced, such as the Cancer Dyspnoea Scale (CDS) [11][12][13]. But the CDS only includes the anxiety as patients' psychological distress and the evidence in terms of its responsiveness and minimal clinically important difference (MCID) is lacking [11][12][13][14].…”

Section: Introductionmentioning

confidence: 99%

“…But the CDS only includes the anxiety as patients' psychological distress and the evidence in terms of its responsiveness and minimal clinically important difference (MCID) is lacking [11][12][13][14]. The Chronic Respiratory Questionnaire (CRQ) is a good candidate for breathlessness assessment [14].…”

Section: Introductionmentioning

confidence: 99%